Home › NDC Lookup › RxCUI directory › RxCUI 992399

Gatifloxacin 5 MG/ML Ophthalmic Solution [Zymaxid] — RxCUI 992399

RxNorm drug concept · Semantic branded drug
RxCUI 992399 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI992399
Official nameGatifloxacin 5 MG/ML Ophthalmic Solution [Zymaxid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZymaxid 0.5 % Ophthalmic Solution; Zymaxid 5 MG/ML Ophthalmic Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gatifloxacin Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zymaxid is an antibiotic eye drop used to treat bacterial pink eye (bacterial conjunctivitis). It targets specific bacteria that commonly cause eye infections, like Staphylococcus...
  • Yes, the schedule is a bit different on the first day. On Day 1, you put one drop in the affected eye every two hours while you're awake, up to 8 times. Starting on Day 2 and throu...
  • How do I use the drops, and does the schedule change over time?
  • The most common things people notice are mild eye irritation, eye pain, and sometimes a strange taste in the mouth — that last one sounds odd, but it happens with eye drops because...
📖 Read our full Gatifloxacin Ophthalmic guide →

🕸️ Concept Web — How Gatifloxacin 5 MG/ML Ophthalmic Solution [Zymaxi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gatifloxacin 5 MG/ML Ophthalmic Solution [Zymaxid] RxCUI 992399

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gatifloxacin 228476
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zymaxid 992396
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gatifloxacin Ophthalmic Solution 402433
    • Gatifloxacin Ophthalmic Product 1156704
    • Gatifloxacin Ophthalmic Solution [Zymaxid] 992398
    • Zymaxid Ophthalmic Product 1186503
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Gatifloxacin 5 MG/ML [Zymaxid] SBDC · 992397
  • Gatifloxacin Ophthalmic Solution [Zymaxid] SBDF · 992398
  • Zymaxid Ophthalmic Product SBDG · 1186503
  • Zymaxid BN · 992396

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 992399 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00023-3615-01 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-01) / 1 mL in 1 BO... ZYMAXID Allergan, Inc. 2010-05-19
00023-3615-25 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-25) / 2.5 mL in 1... ZYMAXID Allergan, Inc. 2010-05-19
Observed labelers: Allergan, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.